Contemplating a Linkage Study?
Researchers and clinicians routinely come across patients with a
particular disease that report further family members which are
affected with the
same or similar symptoms. This will indicate that the disease in
question
is likely to be of genetic origin rather than having environment causes
as it is unlikely that all members of the family will have been exposed
to
the same environmental triggers.. The temptation is to try and identify
the gene and the allele of the gene responsible for the disease.
To identify the gene responsible requires the location of the gene
within the genome. This is done by linkage analysis. It involves the
collection of genetic data from a series of markers in the human genome
which are then tested for co-inheritance with the disease pattern in
the family. Linkage analysis involves the probability calculation of
genetic data on pedigrees to gauge the possibility of a marker being
linked
to a disease.
Diseases can be caused by single genes (examples are Huntington's
disease or Marfan's syndrome) or by a complex interaction of several
genes which may also need environmental triggers (examples are diabetes
and multiple sclerosis).
Linkage studies for Mendelian or single gene disorders are most likely
to succeed with one or several large pedigrees. Affecteds that are
related are much more likely to share the same disease locus and
furthermore the same allele at the disease locus that leads to disease,
thus avoiding complications such as locus and allelic heterogeneity.
For complex diseases allelic and locus heterogeneity are the norm. This
makes the analysis for complex diseases so much more difficult.
Whilst it is possible to carry out power studies they usually only
reflect best case scenarios and are often unrealistic, especially for
complex diseases. Unless you have a highly penetrant simple mendelian
disorder it is unlikely that one small family will provide enough power
to achieve a LOD score of 3. Thus if you are contemplating a study in a
disease inform yourself about the genetic aetiology. Is the disease
likely to be complex? If so have you got a unique clinical subtype that
may allow you to map a mendelian subtype of the disease? If not you
will be looking at a very large study with many affected sibling pairs
or a very large number of pedigrees or even an association study if it
is difficult to find pedigrees with sufficient number of affecteds. If
the phenotype is highly unique and severe it is more likely that the
disease will be Mendelian. An examination of the pedigree may
immediately reveal
the mode of inheritance in this case.
Literature searches pertaining to the disease may reveal that possible
causal genes have already been identified. If this is the case then a
mutation screen of the probable disease gene(s) is a logical first
step, starting
with the known polymorphisms already identified. If this fails to
identify
a causal mutation then a genome wide screen may be called for. This is
a
systematic search of the genome for the location of the gene using
genetic
signposts (the markers).
For genome wide scans we advise the use of the
Australian Genome Research Facility
(AGRF) to carry out the genotyping. The
AGRF has years of experience in
generating high quality genotyping data,
giving you the best chance of locating the disease causing gene. The
AGRF has several commercial sets
of markers that enable the rapid genome wide scanning of individuals
and enable the location of the disease gene. These include a high
density 5cM set and a lower density 10cM set (this means the markers
are spaced at approximately 5 or 10cM apart). The 10 cM set is usually
sufficient for a genome wide scan for a Mendelian disorder. Please
contact
AGRF for pricing and
further details. A recent exciting addition of tools to the linkage
mapper are the 10K, 2 50K SNP chip from
Affymetrix.
The
AGRF now also provides this service.
With costs similar to a 5 cM scan per individual but more information
available this will become a more common alternative from 2004 onwards.
Caution: there are currently some methodological challenges in linkage
mapping utilising such data as assumptions regarding complete linkage
equilibrium are broken for many SNP markers in the chip.
Most of the data preparation programs we have generated have stemmed
from genotyping data from the
AGRF
and thus are tailored to the output from the
AGRF , whether it be from human or
murine linkage or association studies.